NeuroSeriesLive

CME Presentations

GBS and CIDP


Presentations


Speakers

  • Mark D. Pearlmutter, MD, FACEP

    Mark D. Pearlmutter, MD, FACEP

    Mark D. Pearlmutter, MD, FACEP

    Associate Professor of Emergency Medicine and Chair of Emergency Medicine

    Mark D. Pearlmutter, MD, FACEP, is a practicing critical care specialist and chair of emergency medicine at St. Elizabeth’s Medical Center in Brighton, Massachusetts. He is associate professor and chair of emergency medicine at Tufts University School of Medicine in Boston, and is senior vice president of hospital-based services for Steward Health Care, overseeing emergency medicine, radiology, pathology, and the hospitalist service lines. At Tufts University School of Medicine, Dr Pearlmutter serves as chair of various committees, is co-director for the Community Service Learning Program, and founded the Tufts in Haiti Program. He is a past president of the Massachusetts College of Emergency Physicians and received the Vanguard Award for his professional contributions and dedication.
  • Lisa Butler

    Lisa Butler

  • Jon B. Schandler

    Jon B. Schandler

    Jon B. Schandler

    Special Consultant

    Jon B. Schandler retired as CEO of White Plains Hospital (WPH) in White Plains, New York, on April 30, 2015. He joined WPH in 1976 as a controller, and was appointed president and CEO in 1981. Throughout the next 34 years, Mr Schandler steered WPH toward attaining its full potential: expanding its clinical services with each passing year, recruiting outstanding medical talent, and raising funds to transform WPH into a premier regional destination for high-quality health care. Mr Schandler joined the executive team at the Montefiore Health System in 2015 and currently serves as the senior vice president of strategic partnerships. He earned his bachelor’s degree from Villanova University in Villanova, Pennsylvania and an MBA from Fordham University in Bronx, New York.
  • Roy L. Freeman, MD

    Roy L. Freeman, MD

    Roy L. Freeman, MD

    Professor of Neurology

    Roy Freeman, MD, is a professor of neurology at Harvard Medical School and director of the Center for Autonomic and Peripheral Nerve Disorders in the Department of Neurology at Beth Israel Deaconess Medical Center in Boston, Massachusetts. Dr Freeman’s research encompasses the neurological complications of diabetes and other peripheral neuropathies, neuropathic pain, the autonomic complications of Parkinson’s disease and multiple system atrophy, biomarkers in neurodegenerative diseases, and the diagnosis and treatment of autonomic and peripheral nervous system disorders. He is the principal investigator on National Institutes of Health-funded studies on the neurological complications of diabetes and biomarker development in alpha-synucleinopathies.
  • Peter D. Donofrio, MD

    Peter D. Donofrio, MD

    Peter D. Donofrio, MD

    Professor of Neurology

    Peter D. Donofrio, MD, is a professor of neurology, director of the Division of Neuromuscular Disorders, head of the Muscular Dystrophy Association Clinic, the ALS Clinic, and director of the EMG Lab at Vanderbilt University Medical Center in Nashville, Tennessee. His active research interests are polyneuropathy, GBS, CIDP, and motor neuron disorders. Dr Donofrio holds special interest in ALS, myasthenia gravis and peripheral neuropathy, in drug research and clinical trials of medications that could potentially slow the progression of ALS, and in medications that may improve the function of patients with myasthenia gravis. He earned his medical degree from The Ohio State University and completed a neurology residency and fellowship at the University of Michigan.

CME Information

Improving the Recognition of GBS and CIDP in the Hospital Setting


LEARNING OBJECTIVES

Session 1:

  • Recognize signs and symptoms that may suggest a patient is presenting with an acute or chronic inflammatory neuropathy
  • Formulate a differential diagnosis for acute-onset CIDP from GBS and/or other similar neurological conditions
  • Recognize electrodiagnostic testing features that are characteristic of immune-mediated demyelinating neuropathies
  • Identify points of referral for patients with immune-mediated demyelinating neuropathies

Acknowledgement

This activity is supported by an independent educational grant from CSL Behring LLC and Grifols.

Tuition

Complimentary

ACCREDITATION STATEMENT

The activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Albert Einstein College of Medicine and PlatformQ Health Education, LLC. Albert Einstein College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENTS

Live Internet Activity

Albert Einstein College of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Enduring Material

Albert Einstein College of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

OTHER CREDITS

The American Academy of Nurse Practitioners (AANP) and American Nurses Credentialing Center (ANCC) accept AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.

DATE OF RELEASE/EXPIRATION

Live Internet Activity
Tuesday, September 25, 2018 from 12:00 PM EST – 1:00 PM EST

Enduring Material
The enduring material will be available from September 25, 2018 to March 25, 2020.

Certificate of Completion

A Certificate of Completion may be given upon completion of course requirements enabling you to register your credit with the appropriate licensing boards or associations. You may apply for other accreditations using the procedure established by the specific organization

Target Audience

This activity is intended for Neurologists, immunologists, hospitalists, critical care/emergency medicine clinicians, internal medicine and primary care physicians, advanced practice providers, and nurses who may encounter and manage patients with immune-mediated neuropathies such as GBS and CIDP.

ESTIMATED TIME TO COMPLETE

This activity consists of one session, which should take approximately 1 hour to complete.

METHOD OF PARTICIPATION

There are no fees to participate in this activity. To receive credit, participants must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the posttest and activity evaluation. It is estimated that this module will take approximately 1 hour to complete. To receive AMA PRA Category 1 Credit™, participants must receive a minimum score of 70% on the posttest.

HARDWARE/SOFTWARE REQUIREMENTS

Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.

FACULTY DISCLOSURE

The "Conflict of Interest Disclosure Policy" of Albert Einstein College of Medicine requires that faculty participating in any CME activity and anyone in a position to influence content disclose to the audience any relationship(s) with a pharmaceutical or equipment company. Any presenter whose disclosed relationships prove to create a conflict of interest, with regard to their contribution to the activity, will not be permitted to present.

The Albert Einstein College of Medicine also requires that faculty participating in any CME activity and anyone in a position to influence content disclose to the audience when discussing any unlabeled or investigational use of any commercial product, or device, not yet approved for use in the United States.

Presenter

Roy Freeman, MD, MB, ChB Has nothing to disclose relevant to this activity.

Peter D. Donofrio, MD Consulting Fees: CLS Behring

Mark D. Pearlmutter, MD, FACEP Has nothing to disclose relevant to this activity.

Jon B. Schandler Has nothing to disclose relevant to this activity.

Lisa Butler Has nothing to disclose relevant to this activity.

Peer Reviewer

David Kaufman, MD Has nothing to disclose relevant to this activity.

Providers

Einstein–Montefiore Center for Continuing Medical Education The Center for Continuing Medical Education (CCME) staff at Albert Einstein College of Medicine has no disclosures to report relevant to this activity.

PlatformQ Health Education, LLC

David Howard, Medical Director Has nothing to disclose relevant to this activity.

Alissa Yost, Senior Program Manager Has nothing to disclose relevant to this activity.

Contact Information

Please send all inquiries to: Montefiore Medical Center, CCME, 3301 Bainbridge Avenue, Bronx, New York 10467, or via phone at (718) 920-6674, or via fax to (718) 798-2336, or via email to cme@montefiore.org.

For issues with your CME Certificate, please contact NeuroSeriesLive at 877-394-1306 or at Support@NeuroSeriesLive.com.

DISCLAIMERS (if applicable):

The material is prepared based on a review of multiple sources of information but is not exhaustive of the subject matter. Therefore, health care professionals and other individuals should review and consider other publications and materials about the subject matter other than relying solely on the information contained in this material.

The information presented at this CME program represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by Albert Einstein College of Medicine, NeuroSeriesLive, PlatformQ Health Education, LLC or the program grantor. Reasonable efforts have been made to present educational subject matter in a balanced, unbiased fashion and in compliance with regulatory requirements. Each participant must use his/her personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.